Syon Capital LLC Invests $218,000 in The Cooper Companies, Inc. (NASDAQ:COO)

Syon Capital LLC acquired a new stake in The Cooper Companies, Inc. (NASDAQ:COO) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 577 shares of the medical device company’s stock, valued at approximately $218,000.

Other institutional investors have also modified their holdings of the company. Kayne Anderson Rudnick Investment Management LLC lifted its holdings in shares of Cooper Companies by 4.0% during the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,627,596 shares of the medical device company’s stock valued at $517,592,000 after purchasing an additional 62,345 shares during the last quarter. Victory Capital Management Inc. lifted its holdings in shares of Cooper Companies by 16.5% during the fourth quarter. Victory Capital Management Inc. now owns 995,245 shares of the medical device company’s stock valued at $376,641,000 after purchasing an additional 140,700 shares during the last quarter. Invesco Ltd. lifted its holdings in shares of Cooper Companies by 5.9% during the third quarter. Invesco Ltd. now owns 697,045 shares of the medical device company’s stock valued at $221,667,000 after purchasing an additional 39,022 shares during the last quarter. Norges Bank purchased a new stake in shares of Cooper Companies during the fourth quarter valued at $196,045,000. Finally, Northern Trust Corp lifted its holdings in shares of Cooper Companies by 3.4% during the third quarter. Northern Trust Corp now owns 510,353 shares of the medical device company’s stock valued at $162,297,000 after purchasing an additional 16,571 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Stock Performance

Shares of COO stock opened at $91.66 on Wednesday. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.95 and a quick ratio of 1.14. The firm has a market cap of $18.25 billion, a P/E ratio of 53.84, a PEG ratio of 2.32 and a beta of 1.02. The stock’s 50-day moving average is $93.32 and its two-hundred day moving average is $94.55. The Cooper Companies, Inc. has a fifty-two week low of $75.93 and a fifty-two week high of $104.07.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, May 30th. The medical device company reported $0.85 EPS for the quarter, beating analysts’ consensus estimates of $0.83 by $0.02. The business had revenue of $942.60 million for the quarter, compared to analyst estimates of $948.07 million. Cooper Companies had a return on equity of 8.87% and a net margin of 9.11%. The firm’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.77 EPS. Analysts predict that The Cooper Companies, Inc. will post 3.57 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on COO. Citigroup increased their price objective on Cooper Companies from $108.00 to $116.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. Robert W. Baird increased their price objective on Cooper Companies from $116.00 to $118.00 and gave the stock an “outperform” rating in a research note on Friday, May 31st. Redburn Atlantic raised Cooper Companies from a “neutral” rating to a “buy” rating and set a $125.00 price objective for the company in a research note on Tuesday, March 19th. Piper Sandler increased their price objective on Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a research note on Friday, March 1st. Finally, TheStreet downgraded Cooper Companies from a “b-” rating to a “c” rating in a research note on Thursday, February 29th. Four equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat, Cooper Companies presently has an average rating of “Moderate Buy” and a consensus price target of $111.42.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.